KR0149483B1 - Antiplague compositions - Google Patents

Antiplague compositions Download PDF

Info

Publication number
KR0149483B1
KR0149483B1 KR1019920018405A KR920018405A KR0149483B1 KR 0149483 B1 KR0149483 B1 KR 0149483B1 KR 1019920018405 A KR1019920018405 A KR 1019920018405A KR 920018405 A KR920018405 A KR 920018405A KR 0149483 B1 KR0149483 B1 KR 0149483B1
Authority
KR
South Korea
Prior art keywords
composition
extract
oral hygiene
sodium
toothpaste
Prior art date
Application number
KR1019920018405A
Other languages
Korean (ko)
Other versions
KR940008670A (en
Inventor
하재몽
김문무
정광래
서성수
Original Assignee
최근선
주식회사럭키
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 최근선, 주식회사럭키 filed Critical 최근선
Priority to KR1019920018405A priority Critical patent/KR0149483B1/en
Publication of KR940008670A publication Critical patent/KR940008670A/en
Application granted granted Critical
Publication of KR0149483B1 publication Critical patent/KR0149483B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)

Abstract

초두구, 맥문동, 형개, 목단피 및 치자 중에서 선택된 1 종 또는 2 종 이상의 생약 추출물을 함유하는 구강위생 증진용 조성물.Oral hygiene composition comprising one or two or more herbal extracts selected from chodugu, munmundong, hyunggeul, neck skin and gardenia.

Description

생약추출물을 함유한 구강위생 증진용 조성물Oral Hygiene Composition Containing Herbal Extracts

본 발명은 치주질환 예방, 치료 및 충치예방과 효과가 우수한 구강위생 증진용 조성물에 관한 것으로서, 더욱 상세하게는 생약약재로부터 추출한 생약성분을 구강 조성물에 적용하므로서 치주질환 예방, 치료 및 충치예방효과를 증진시킨 구강위생 증진용 조성물에 관한 것이다.The present invention relates to a composition for preventing or treating periodontal disease and preventing oral hygiene and having excellent effects, and more particularly, applying the herbal ingredient extracted from a herbal medicine to an oral composition to prevent and treat periodontal disease, and to prevent tooth decay. It relates to a composition for enhancing oral hygiene.

치과 질환은 고대의 문화권을 형성하고 있었던 이집트의 미이라에서 이미 발견할 수 있었으며, B.C 3,000 년대 바빌론과 앗시리아인은 충치질환과 치주질환에 대한 예방과 치료를 위해 어떤 약재의 환이나 양치약을 사용한 기록이 있다(Ramirex, J.M. et al, Periodont, Abst. 18:139-142, 1970).Dental diseases could already be found in Egyptian mummies that formed ancient cultures, and in the 3,000 BC Babylon and Assyrians used records of medicinal herbs or dentifrices to prevent and treat tooth decay and periodontal disease. (Ramirex, JM et al, Periodont, Abst. 18: 139-142, 1970).

동양에서는 중국에서 기원전 2,697 년 황제 황화이(Hwang-Fi)에 의하여 구강질환을 염증, 치주질환, 충치 등으로 분류하여 이를 치료하기 위해 약초를 사용하였다는 것이 알려져 있다.In the Orient, it is known that Chinese medicine was used to treat oral diseases by inflammation, periodontal disease and tooth decay by Hwang-Fi in 2,697 BC.

오늘날에 이르러 치과질환의 원인으로서의 치태에 관한 연구를 각종 약재에 의한 치태 형성 억제제로서 항생제, 효소제, 기타 화학약제들의 연구가 활발히 진행되고 있다. 특히, 한국을 중심한 동약의 각국에서 치과영역 질환의 치료를 위해 한약제를 널리 이용하고 각종 처방에 적용하고 있다.To date, studies on plaque as a cause of dental diseases have been actively conducted by antibiotics, enzymes, and other chemical agents as plaque inhibitors by various medicines. In particular, the use of herbal medicine for the treatment of dental diseases in the countries of the East, mainly in Korea, and is applied to various prescriptions.

한약재 등으로부터 성분을 추출하여 치주질환에 적용한 공지 생약추출물들로는 황백등에서 추출하여 구강조성물에서 적용한 베르베린 추출물이 있고 (일본국 공개특허 공보 소 57-56, 415 호, 등 57-85, 319 호), 감초 추출물을 배합한 것 또는 골취브, 측백염, 지유, 연근, 애엽 등의 생약추출물을 배합한것 (일본국 공개특허 공보 소 55-120, 509 호) 등이 알려져 있다.Known herbal extracts extracted from herbal medicines and applied to periodontal disease include berberine extracts extracted from yellow and white and applied to oral compositions (JP-A-57-56, 415, et al. 57-85, 319), Compounds containing licorice extract or those containing herbal extracts such as bone stalks, leukostatitis, fat milk, lotus root and leaf loaves (Japanese Patent Laid-Open No. 55-120, 509) and the like are known.

본 발명자들은 종래 문헌상에서 치주질환에 사용한 약재들과 민간에서 사용하고 있는 약지를 중심으로 하여 충추질환 및 치주질환에 유효한 성분들을 추출하여 확인하는 과정에서 항염증작용, 지혈작용, 치태형성 억제작용이 우수하고, 구취제거 효과가 좋으며, 맛이 양호하여 사용감이 뛰어난 추출물을 발견하고 본 발명을 완성하게 되었다.The present inventors have anti-inflammatory action, hemostatic action, plaque formation inhibitory effect in the process of extracting and confirming effective ingredients for tooth decay disease and periodontal disease centering on the medicines used for periodontal disease and the medicinal herbs used in the private sector in the prior literature. Excellent, good bad breath removal effect, good taste to find an extract with excellent feeling and to complete the present invention.

본 발명의 생약추출물은 수증기증류추출, 에탄올추출 및 메탄올추출에 의하여 제조되었다. 수증기 증류추출은 세말 또는 조절된 상태의 약재를 추출기에 넣고 물을 넣어 끓여서 생약성분을 추출하여 농축, 건조시키거나 물을 증류시켜 수증기가 추출기에 혼입되게 하여, 혼입된 수증기에 의해서 생약의 황성성분이 추출되게 하여 추출된 추출액을 여과하고, 이것을 감압농축시킨 후 건조하여 과립화 상태로 만들며, 에탄올 및 메탄올 추출물은 퍼콜레이션법에 따라 제조하여 감압농축시킨 후 과립상태로 만들거나 탄크제 상태로 그대로 사용한다.The herbal extract of the present invention was prepared by steam distillation extraction, ethanol extraction and methanol extraction. Steam distillation extracts medicinal herbs in a fine or controlled state into an extractor and boils with water to extract the herbal ingredients and concentrate or dry them, or distill water so that steam is incorporated into the extractor. The extract was filtered to extract the extract, and the resultant was concentrated under reduced pressure and dried to obtain a granulated state. Ethanol and methanol extracts were prepared according to the percolation method, and concentrated under reduced pressure to make granules or as a tank. use.

더욱 구체적으로, 본 발명은 초두구, 맥문동, 형개, 목단피, 치자중에서 선택된 1 종 또는 2 종 이상의 생약추출물을 함유하는 구강위생 증진용 조성물을 제공한다.More specifically, the present invention provides a composition for enhancing oral hygiene, containing one or two or more herbal extracts selected from cedar, munmundong, mold opening, neck peel, and gardenia.

본 발명의 구강위생 증진용 조성물은 생약추출물 단독 또는 2 종 이상을 혼합하며 조성물 총중량당 0.01 내지 10 중량% 함유하는 것이 바람직하다. 상기 성분을 0.01 중량 % 이하로 사용할 때에는 치주질환 예방, 치료 및 충치예방 효과가 미약하게 되고, 10 중량% 이상 사용할 때는 추출물의 각 성분이 특이한 맛에 의해 제품의 사용감을 저하시키게 된다.Oral hygiene-promoting composition of the present invention preferably contains only 0.01 to 10% by weight of the total weight of the composition of the herbal extracts alone or mixed two or more kinds. When the component is used at 0.01 wt% or less, the effect of preventing, treating and preventing tooth decay is weakened. When used at 10 wt% or more, each component of the extract lowers the usability of the product due to its unique taste.

본 발명에서 생약추출물은 과립상태이고 그 함량이 0.01 내지 5 중량% 인 것이 바람직하다. 또한 본 발명에서 생약추출물은 틴크제이고 그 함량이 0.05 내지 10 중량% 인 것이 바람직하다.In the present invention, the herbal extract is in a granular state, and the content thereof is preferably 0.01 to 5% by weight. In addition, the herbal extract in the present invention is a tin agent and the content is preferably 0.05 to 10% by weight.

본 발명의 구강위생 증진용 조성물은 구강제품인 치약, 구강청정제, 의치세정제, 츄임껌 등의 통상적인 성분에 치주질환 예방, 치료 및 충치예방 효과가 우수한 약용 성분으로서 초두구, 맥문동, 형개, 복단피, 치자등의 추출물을 단곡 또는 2 종 이상 혼합사용하여 제조할수 있다.Oral hygiene-promoting composition of the present invention as a medicinal ingredient excellent in preventing or treating periodontal disease, treatment and tooth decay effects on conventional ingredients such as toothpaste, mouthwash, denture cleaner, chewing gum, oral products, such as chondura, pulmonary dong, mold opening, abdominal skin , Extracts of gardenia, etc. can be prepared by using single or two or more kinds.

본 발명이 성분으로 구강조성물의 종류 및 사용목적에 따라 통상 사용하는 성분의 적당량을 사용하여 배합하였다. 예를 들어 본 발명의 치약성분들은 통상적인 연마제, 습윤제, 결합제, 기포제, 감미제, 방부제, 향료, PH 조정제, 증백제 등을 함유할 수 있다.The present invention is formulated using an appropriate amount of the component commonly used according to the type and purpose of the oral composition as a component. For example, the toothpaste components of the present invention may contain conventional abrasives, wetting agents, binders, foaming agents, sweeteners, preservatives, fragrances, PH adjusters, brighteners and the like.

연마제로는 탄산칼륨, 인산일수소칼슘, 침강실리카, 함수알루미나, 실리카겔, 불용성 메타인산 나트륨, 지르코늄 실리게이트 등이 있으며, 이들 연마제를 단독 혹은 2 종 이상 혼합하여 20 내지 60 중량%, 바람직하게는 20 내지 50 중량% 사용한다.Examples of the abrasive include potassium carbonate, calcium dihydrogen phosphate, precipitated silica, hydrous alumina, silica gel, insoluble sodium metaphosphate, and zirconium silicate. These abrasives may be used alone or in combination of two or more thereof, preferably 20 to 60% by weight. 20 to 50% by weight is used.

습윤제로는 글리세린, 솔비톨액, 비결정성 솔비톨액을 단독 혹은 2 종 이상 혼합하여 20 내지 60 중량%, 바람직하게는 20 내지 50 중량%를 사용한다.As the humectant, 20 to 60% by weight, preferably 20 to 50% by weight, of glycerin, sorbitol solution, and amorphous sorbitol solution alone or in combination of two or more thereof is used.

결합제로는 카라기난, 잔탄껌, 카르복시 메칠셀룰로오스 나트륨, 카르복시 비닐폴리머(상품명 : 카르보폴), 알긴산 나트륨등 단독 또는 2 종 이상 혼합하여 0.1 내지 3.0 중량%, 바람직하게는 0.5 내지 2.0 중량%를 사용한다.As the binder, 0.1 to 3.0% by weight, preferably 0.5 to 2.0% by weight of carrageenan, xanthan gum, sodium carboxymethyl cellulose, carboxy vinyl polymer (trade name: Carbopol), sodium alginate, or a mixture of two or more thereof is preferably used. .

기포제로는 라우릴 황산 나트륨, 라우릴 사르코신산 나트륨등의 음이온 계면활성제와 소르비탄 지방산 에스테르, 폴리옥시 에틸렌 경화 피마자유, 폴리옥시 에틸렌 폴리옥시 프로필렌계 축합 고분자 물질등을 단독 또는 혼합하여 0,5 내지 5 중량%, 바람직하게는 0.5 내지 2.5 중량%를 사용한다.As the foaming agent, anionic surfactants such as sodium lauryl sulfate and sodium lauryl sarcosinate, sorbitan fatty acid esters, polyoxyethylene-cured castor oil, polyoxyethylene polyoxypropylene-based condensed polymer materials, etc. may be used alone or in a mixture. To 5% by weight, preferably 0.5 to 2.5% by weight.

감미제로는 삭카란 나트륨, 아스파탐, 스테비오시드, 감초산등을 들수 있으며, 적당하기로는 단독 또는 2 종이상 혼합하여 0.05 내지 0.5 중량%를 사용한다.Examples of sweeteners include saccharan sodium, aspartame, stevioside, and licorice acid, and suitable amounts of 0.05 to 0.5 wt% are used alone or in mixture of two species.

방부제로는 파라옥시안식향산 에스텔, 안식향산, 안식향산 나트륨을 단독 또는 2 종이상 혼합사용하며, 약효제로는 불화나트륨, 클로로헥시딘, 트라넥사민산, 알란토인류, 카프론산, 감초엑기스, 산페논 생귀나린 엑기스, 황백 엑기스, 베르베린, 글리시리진을 사용한다. 향료로는 페파민트오일, 스페아민트 오일, 멘톨, 카르본등을 적당량 혼합 사용하며, PH 조정제로는 인산, 인산나트륨, 구연산, 구연산 나트륨, 호박산, 호박산나트륨, 주석산, 주석산나트륨 등을 사용하며 적당한 PH 범위로는 5 내지 8 중량% 이다. 증백제로는 산화티탄을 사용하며, 적당하기로는 0.1 내지 5 중량 % 이다.As the preservative, paraoxybenzoic acid ester, benzoic acid, sodium benzoate is used alone or in mixture of two species.As a medicinal agent, sodium fluoride, chlorohexidine, tranexamic acid, allantoin, capronic acid, licorice extract, sanphenone extract Use narin extract, yellow white extract, berberine and glycyrrhizin. As a flavoring agent, a suitable amount of peppermint oil, spearmint oil, menthol, and carbon are mixed. As a pH adjuster, phosphoric acid, sodium phosphate, citric acid, sodium citrate, succinic acid, sodium succinate, tartaric acid and sodium stannate are used. The range is 5 to 8% by weight. Titanium oxide is used as the brightener, and preferably 0.1 to 5% by weight.

[실험예 1]Experimental Example 1

이 실험에는 구강 미생물에 대한 생약추출물들의 살균력 시험이다.This test is a test of the bactericidal activity of herbal extracts against oral microorganisms.

[생약추출물 종류][Medicinal Herb Extracts]

감극, 감초, 계지, 금은화, 대황, 도인, 맥문동, 목단피, 길경, 세신, 연교, 인진호, 천궁, 초두구, 형개, 황금, 황백, 치자등Gapuk, Licorice, Gyeji, Gold and Silver Coins, Rhubarb, Doin, Macmun-dong, Peel, Peel, Gilgyeong, Sesin, Yeongyo, Injinho, Cheongung, Chodugu, Hyeonggae, Golden, Yellow White, Gardenia

[시험균주][Test strain]

스트렙토코카즈 뮤탄즈 (Streptococcus mutans 10449, 혈청형 C)Streptococcus mutans 10449, serotype C

로티아 덴토카리오사 (Rothia dentocariosa)Rothia dentocariosa

스트렙토코카즈 미티즈 (Streptococcus mitis)Streptococcus mitis

악티노 마이세스 비스코서스 (Actinomyces viscosus)Actinomyces viscosus

[시험방법][Test Methods]

각 추출물 0.1g을 10mm 의 BHI(Brain Heart Infusion)에 첨가한 후 1 내지 2 일 배양한 균주를 접종시켜 1 내지 2 일 배양한 후 생균수를 측정하였다.0.1 g of each extract was added to 10 mm of BHI (Brain Heart Infusion), and then inoculated with the strain cultured for 1 to 2 days, and then cultured for 1 to 2 days.

[실험결과][Experiment result]

살균력 실험경과 초두구, 질경, 맥문동, 형개, 목단피, 인진호, 황백, 치자등이 유의한 효과를 나타내었다.The bactericidal test, chondura bulb, plantain, pulmonary dong, hyunggae, neck skin, Injinho, Hwangbaek, and Gardenia showed significant effects.

[실시예 1 내지 3][Examples 1-3]

구강 위생 증진용 조성물 중 치약 조성물의 제조 순서는 습윤성분인 비결정성 솔비톨액에 카르복시메틸 셀룰로오스 나트륨, 삭카린, 방부제등 분말 소량 성분을 분산시키고 정제수로 묽힌 다음 혼합기에서 1차 혼합하고, 그 다음에 인산일수소칼슘등의 연마제를 혼합했다.In order to prepare the toothpaste composition in the composition for promoting oral hygiene, a small amount of powder components such as sodium carboxymethyl cellulose, saccharin, and preservatives are dispersed in an amorphous sorbitol liquid as a wet component, diluted with purified water, and then mixed in a mixer firstly. Abrasives, such as calcium dihydrogen phosphate, were mixed.

그리고 마지막으로 기포제인 알킬황산 나트륨, 안정제류, 향료성분등을 넣고 진공 상태하에서 3 차 혼합하므로서 치약조성물을 제조하였다. 기타의 구강 위생 증진용 조성물의 제조는 통상적인 제조 순서에 따라 제조하였다.And finally, the toothpaste composition was prepared by adding a foaming agent sodium sulfate, stabilizers, fragrance components, etc. and tertiary mixing under vacuum. The preparation of the other oral hygiene-promoting compositions was made according to conventional manufacturing procedures.

실시에 1 내지 3과 비교예 1 내지 4 치약의 치태생성 역제효과, 치은염증 완화효과 비교시험Comparison of the plaque production adverse effects and gingivitis relief effects of Examples 1 to 3 and Comparative Examples 1 to 4 toothpaste

[실험예 2]Experimental Example 2

표 2의 실시예 1 내지 3 과 비교예 1 내지 4 의 치약을 사용하여 치태 형성 억제 작용을 실험하였다.Tooth plaque formation inhibitory effect was tested using the toothpaste of Examples 1 to 3 and Comparative Examples 1 to 4 of Table 2.

[실험구조]Experimental Structure

스트렙토코카즈 뮤탄즈 (Streptococcus mutans 10449, 혈청형 C)Streptococcus mutans 10449, serotype C

[실험방법]Experimental Method

가. 실험군주를 BHI 배지(Brain-heart infusion agar)에서 배양하고 이균을 백금이로 THB 배지(Todd Hewit Broth)에 접종하여 37℃에서 15 내지 16 시간동안 배양한다.end. Experimental incubator is incubated in BHI medium (Brain-heart infusion agar) and inoculated in THB medium (Todd Hewit Broth) with the bacteria incubated at 37 ℃ for 15 to 16 hours.

나. 치태형성 억제시험을 위하여 직경 2mm, 길이 7㎝ 유리봉을 준비하여 180℃에서 2 시간동안 건조기에서 멸균시킨후 무게를 측정한다.I. For plaque formation inhibition test, prepare a glass rod with a diameter of 2mm and a length of 7cm, sterilize at 180 ℃ for 2 hours, and weigh.

다. 유리봉을 1% 슈크로즈 (w/v) 를 포함하는 THB 배지가 들어 있는 실험관에 넣고 실시예 및 비교예 치약의 시험용액을 일정한 농도 첨가한 후 스트렙토코카즈 뮤탄즈 0.1mm 를 첨가하여 37℃에서 24 시간 배양한다.All. The glass rod was placed in a test tube containing THB medium containing 1% sucrose (w / v), and a test solution of the toothpaste of Examples and Comparative Examples was added at a constant concentration, followed by adding 0.1 mm of streptococcal mutanz to 37 ° C. Incubate for 24 hours.

라. 배양후 유리봉을 조심스럽게 들어내어 37℃에서 하루동안 건조시킨 후 최종무게를 측정한다. 대조군은 시험용액을 첨가하지 않은 시험군으로 한다.la. After incubation, carefully lift the glass rod and dry it at 37 ° C for one day, and then measure the final weight. The control group is the test group without the test solution.

* 치약의 시험용액 제조* Preparation of test solution of toothpaste

각 치약의 50 중량% 용액을 만들어 불용분을 원심분리시켜 제거한후 여액을 시험용액으로 한다.Make a 50% by weight solution of each toothpaste, remove the insolubles by centrifugation, and use the filtrate as a test solution.

[실험결과][Experiment result]

실험결과는 하기 표 3 과 같다.The experimental results are shown in Table 3 below.

표 3 의 결과는 실시예 1 내지 3 과 비교예 2 내지 3 은 치태형성 억제작용에 효과가 있는 것으로 나타났다.The results of Table 3 showed that Examples 1 to 3 and Comparative Examples 2 to 3 are effective in inhibiting plaque formation.

[실험예 3]Experimental Example 3

표 2 이 실시예 1 내지 3 과 비교예 1 내지 4 의 치약을 사용하여 치은염증 완화효과를 비교시험하였다.Table 2 was used to compare the gingival inflammation relief effect using the toothpaste of Examples 1-3 and Comparative Examples 1-4.

본 발명 치약과 비교예 치약을 가지고 매일 3 회씩 (각 3 분간) 20일간 양치질하게 하고 잇몸의 색상변화를 측정하여 잇몸의 건강상태 유지 및 개선효과를 비교 시험하였다. 색상변화는 일본전색의 I 80 색차계를 사용하였다.The toothpaste of the present invention and the comparative example toothpaste was brushed three times daily (for 3 minutes each) for 20 days and the color change of the gum was measured to compare and maintain the health condition and improvement effect of the gums. For color change, I80 color difference meter of all colors of Japan was used.

통상 건강한 잇몸일수록 명도지수가 크고, 적색도가 높으며, 황색도는 낮게 나타난다. 즉 선명한 홍색을 나타내게 된다.Normally, healthy gums have a higher brightness index, higher redness, and lower yellowness. That is, a bright red color will appear.

[실험결과][Experiment result]

실시예 1 내지 3 은 비교예 1 과 비교예 4 에 비하여 선명한 홍색을 나타내므로 치은 염증 완화작용이 우수함을 나타내며, 비교예 2 내지 3 은 치은염증 완화작용은 우수하나 치약에 함유된 생약 엑기스의 독특한 맛 때문에 치약사용감이 불량하였다.Examples 1 to 3 show a clear red color as compared to Comparative Example 1 and Comparative Example 4 shows excellent gingival inflammation alleviating effect, Comparative Examples 2 to 3 have excellent gingivitis alleviating effect but unique of the herbal extract contained in toothpaste The toothpaste feeling was poor because of the taste.

[실시예 4 : 치약]Example 4 Toothpaste

일산일수소칼슘 40.0%Calcium Hydrogen Monoxide 40.0%

함수알루미나 5.0%Hydrous alumina 5.0%

산화티탄 1.0%Titanium Oxide 1.0%

비결정성솔비톨액 30.0%Amorphous Sorbitol Liquid 30.0%

알킬황산나트륨 1.5%Alkyl sodium sulfate 1.5%

삭카린 나트륨 0.1%Zaccarin Sodium 0.1%

파라옥시안식향산에스테르 0.1%Paraoxybenzoic acid ester 0.1%

카르복시메틸셀룰로스 나트륨 1.0%Carboxymethylcellulose Sodium 1.0%

초두구 엑기스 0.1%Green bean extract 0.1%

형개 엑기스 0.1%Mold opening extract 0.1%

감초 엑기스 0.1%Licorice Extract 0.1%

향료 1.0%Spices 1.0%

정제수 가하여 100.0%100.0% by adding purified water

[실시예 5 : 구강 청정제]Example 5 Oral Cleanser

에탄올 (90%) 20.0%Ethanol (90%) 20.0%

글리세린 (98%) 10.0%Glycerin (98%) 10.0%

폴리옥시에틸렌폴리옥시 1.0%Polyoxyethylene Polyoxy 1.0%

프로필렌 공중합체Propylene copolymer

초두구 엑기스 01.%Super Chill Extract 01.%

치자 엑기스 0.1%Gardenia extract 0.1%

맥문동 엑기스 0.1%Macmundong Extract 0.1%

삭카린 나트륨 0.1%Zaccarin Sodium 0.1%

향료 1.0%Spices 1.0%

정제수 가하여 100.0%100.0% by adding purified water

[실시예 6 : 의치세정제 (정제)]Example 6 Denture Cleaner (Tablet)

탄산수소나트륨 30.0%Sodium bicarbonate 30.0%

주석산 27.0%Tartaric acid 27.0%

코코일사르코신산나트륨 5.0%Sodium Cocoyl Sarcosate 5.0%

라우릴 황산나트륨 5.0%Sodium Lauryl Sulfate 5.0%

염화벤잘코니음 2.0%Benzalconium chloride 2.0%

EDTA 나트륨 5.0%EDTA Sodium 5.0%

트리폴리인산나트륨 14.0%Sodium tripolyphosphate 14.0%

폴리에틸렌글리콜 2.0%Polyethylene Glycol 2.0%

초두구 엑기스 0.2%Super bean extract 0.2%

형개 엑기스 0.1%Mold opening extract 0.1%

향료 적 량Spices

[실시예 7 : 츄임껌]Example 7 Chewing Gum

껌 베이스 25.0%Gum base 25.0%

솔비톨 44.0%Sorbitol 44.0%

만니톨 12.0%Mannitol 12.0%

글리세린 13.0%Glycerin 13.0%

렉시딘 0.5%Lexidine 0.5%

감미제 2.0%Sweetener 2.0%

초두구 엑기스 0.1%Green bean extract 0.1%

맥문동 엑기스 0.1%Macmundong Extract 0.1%

형개 엑기스 0.1%Mold opening extract 0.1%

향료 적 량Spices

실시예 1 내지 7 은 모두 치주질환 예방, 치료 및 충치예방에 우수한 효과가 있음을 알 수 있다.It can be seen that Examples 1 to 7 all have excellent effects on preventing, treating and preventing tooth decay.

Claims (6)

맥문동, 형개, 목단피 및 치자 중에서 선택된 1 종 또는 2종 이상의 생약 추출물을 초두구추출물과 함께 함유됨을 특징으로 하는 살균효과, 치태형성억제효과 및 치은염증완화 효과를 갖는 구강위생 증진용 조성물.Oral hygiene composition with bactericidal effect, plaque formation inhibitory effect and gingival inflammation relieving effect, characterized in that it contains one or two or more herbal extracts selected from the pulse worm, mold opening, neck peel and gardenia together with the head extract. 제1항에 있어서, 상기 추출물이 과립상태이고, 그 함량이 0.01 내지 5 중량%임을 특징으로 하는 구강위생 증진용 조성물.According to claim 1, wherein the extract is in a granular state, the content of the oral hygiene composition, characterized in that the content of 0.01 to 5% by weight. 제1 또는 2항에 있어서, 구강위생 증진용 조성물이 치약된 조성물.The composition of claim 1 or 2, wherein the composition for promoting oral hygiene is toothpaste. 제1 또는 2항에 있어서, 구강위생 증진용 조성물이 구강 청정제인 조성물.The composition according to claim 1 or 2, wherein the composition for promoting oral hygiene is an oral cleaning agent. 제1 또는 2항에 있어서, 구강위생 증진용 조성물이 위치 세정제인 조성물.The composition of claim 1 or 2, wherein the composition for promoting oral hygiene is a positional cleanser. 제1 또는 2항에 있어서, 구강위생 증진용 조성물이 츄임껌인 조성물.The composition according to claim 1 or 2, wherein the composition for promoting oral hygiene is chewing gum.
KR1019920018405A 1992-10-07 1992-10-07 Antiplague compositions KR0149483B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019920018405A KR0149483B1 (en) 1992-10-07 1992-10-07 Antiplague compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019920018405A KR0149483B1 (en) 1992-10-07 1992-10-07 Antiplague compositions

Publications (2)

Publication Number Publication Date
KR940008670A KR940008670A (en) 1994-05-16
KR0149483B1 true KR0149483B1 (en) 1998-10-15

Family

ID=19340769

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920018405A KR0149483B1 (en) 1992-10-07 1992-10-07 Antiplague compositions

Country Status (1)

Country Link
KR (1) KR0149483B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100537834B1 (en) * 2000-12-21 2005-12-19 주식회사 엘지생활건강 Oral Compositions against Halitosis
KR100538154B1 (en) * 2002-04-30 2005-12-21 주식회사 싸이클로젠 Extra cts of crude drug
KR100750474B1 (en) * 2001-02-08 2007-08-22 주식회사 엘지생활건강 Oral compositions against breath

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100537834B1 (en) * 2000-12-21 2005-12-19 주식회사 엘지생활건강 Oral Compositions against Halitosis
KR100750474B1 (en) * 2001-02-08 2007-08-22 주식회사 엘지생활건강 Oral compositions against breath
KR100538154B1 (en) * 2002-04-30 2005-12-21 주식회사 싸이클로젠 Extra cts of crude drug

Also Published As

Publication number Publication date
KR940008670A (en) 1994-05-16

Similar Documents

Publication Publication Date Title
KR101955468B1 (en) Preparing method for toothpaste composition comprising natural extracts
KR102408893B1 (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
KR20170141053A (en) Composition for prevention or treatment of dental disease comprising an extract of Gardenia jasminoides
KR102562835B1 (en) Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract
KR20170141034A (en) Composition for prevention or treatment of dental disease comprising Panax ginseng extract
KR101881636B1 (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
KR0149483B1 (en) Antiplague compositions
CN110613801B (en) Oral composition for preventing or improving oral diseases and use thereof
KR20170142740A (en) Composition for treating or preventing oral diseases comprising natural complex
KR102415612B1 (en) Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract
KR0138248B1 (en) The oral cavity hygienic compositions
KR20170103482A (en) Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract
KR0138247B1 (en) The oral cavity hygienic compositions
KR102562830B1 (en) Composition for prevention or treatment of oral disease comprising Kochiae Fructus Extract
KR101818211B1 (en) Composition for prevention or treatment of oral disease comprising Arctill fructus Extract
KR102562829B1 (en) Composition for prevention or treatment of oral disease comprising Alpinia officinarum Extract
KR102548925B1 (en) Composition for prevention or treatment of oral disease comprising Scopoletin
KR102562831B1 (en) Composition for prevention or treatment of oral disease comprising Gleditsiae fructus Extract
KR102156884B1 (en) Composition for prevention or treatment of oral disease comprising Meliae toosendan fructus Extract
KR102564564B1 (en) Composition for prevention or treatment of oral disease comprising 2-methoxycinnamaldehyde
KR20170141057A (en) Composition for prevention or treatment of dental disease comprising an extract of Daphne genkwa
KR102541843B1 (en) Composition for prevention or treatment of oral disease comprising Arctiin
KR102417082B1 (en) Composition for prevention or treatment of oral disease comprising Celosia argentea Extract
KR102580941B1 (en) Composition for prevention or treatment of oral disease comprising Qucercetin 3-glucoside
KR20200107917A (en) Composition for prevention or treatment of oral disease comprising Meliae toosendan fructus Extract

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20080318

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee